|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $94,375,771 | $93,955,376 | $136,841,548 | $130,512,699 | $103,949,707 | $101,903,916 | $137,185,431 |
| Streptomycins & their derivs.; salts thereof | $3,425,327 | $3,796,438 | $4,102,335 | $4,691,948 | $40,421,640 | $46,242,469 | $50,168,784 |
| Tetracyclines & their derivs.; salts thereof | $7,729,365 | $5,503,056 | $8,393,305 | $6,412,788 | $10,085,972 | $5,945,362 | $11,668,286 |
| Chloramphenicol & its derivs.; salts thereof | $1,264,784 | $289,327 | $132,337 | $336,868 | $81,297 | $61,474 | $53,425 |
| Erythromycin & its derivs.; salts thereof | $28,831,985 | $10,185,730 | $41,505,366 | $76,344,437 | $12,695,060 | $23,598,313 | $14,011,522 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $206,464,383 | $152,106,085 | $160,907,553 | $95,771,545 | $75,140,895 | $79,415,469 | $162,252,867 |
| Total | $342,091,615 | $265,836,012 | $351,882,444 | $314,070,285 | $242,374,571 | $257,167,003 | $375,340,315 |
|
|
